Searchable abstracts of presentations at key conferences in endocrinology

ea0029p1629 | Thyroid (non-cancer) | ICEECE2012

Clinical presentation (symptoms and complications) of hyperthyroidism in a cohort of 1,144 patients: results of the Thyrdel study

Goichot B. , Bouee S. , Ndaye N. , Caron P. , Landron F.

Symptoms and physical signs are variable and non specific in hyperthyroidism (HT). We report the results of a large study conducted among 263 French endocrinologists. Each investigator was asked to include all consecutive patients seen for HT during the study period. For each patient, symptoms, physical signs, biological data and treatment were recorded. The endocrinologists included 1,144 patients with HT: 802 Grave’s disease (GD), 121 multinodular goitres (MNG), 112 iat...

ea0029p1668 | Thyroid (non-cancer) | ICEECE2012

Diagnosis and therapeutic practices of hyperthyroidism in france. results of a survey on 263 endocrinologists and 1214 patients (the thyrdel study)

Goichot B. , Caron P. , Bouee S. , Luca F. , Landron F.

There are considerable variations in diagnosis and therapeutical practices in hyperthyroidism (HT) between countries. Few of these differences rely on a scientific basis. we present the results of a study conducted among a representative sample of 263 French endocrinologists. All consecutive patients seen for HT during the study period were included. Symptoms, biological data and treatment were recorded. 1214 patients with hyperthyroidism were included, 1144 had an identified ...

ea0029p1617 | Thyroid (non-cancer) | ICEECE2012

Subclinical hyperthyroidism (SH) in the elderly: symptoms, depression and quality of life (QoL) and relationship with TSH concentration in a prospective cohort of 110 patients

Goichot B. , Vinzio S. , Kuhn J. , Meyer N. , Wemeau J. , Caron P. , Luca F. , Orgiazzi J.

SH is defined by a decrease of TSH with normal thyroid hormone (TH) concentrations. The clinical picture is not clear, whether these patients may have symptoms or alterations of QoL. It is well known that in overt hyperthyroidism, symptoms may be absent in old patients. In SH, one study in young patients has reported an increased symptom score and a slight decrease of QoL but these results have not been confirmed in middle-aged subjects. We report the initial data of the Pirat...

ea0029p814 | Endocrine tumours and neoplasia | ICEECE2012

Efficacy of Everolimus to prevent hypoglycemia in patients with metastatic insulinomas: for the French group of endocrine tumors (GTE-Renaten)

Bernard V. , Lombard-Bohas C. , Goichot B. , Rohmer V. , Guimbaud R. , Niccoli P. , Chougnet C. , Ruszniewski P. , Baudin E.

Background: Refractory hypoglycemia in patients with metastatic insulinomas (RHMI) is an important cause of morbidity and mortality and everolimus could be a new therapeutic option.Methods: We conducted a restrospective multicentric study within the French group of endocrine tumors to evaluate the time to first symptomatic recurrence (TSR) in patients with RHMI after everolimus initiation. Ongoing hyperglycemic medical options and safety were recorded.</...